Advances in the Treatment of Myelofibrosis: Clinical Trial Data of Next Generation Therapeutics – Live

Read more
CancerNet

Changing Landscape of DLBCL Treatment: ADCs, Bispecific Antibodies, CAR T Therapies, and Combinations – Live

Read more
CancerNet

PI3K/AKT/mTOR Pathway Inhibitors in the Treatment of HR+/HER2- Metastatic Breast Cancer – Live

Read more
CancerNet

Changing Landscape of Diagnosis and Personalized Therapies for Acute Myeloid Leukemia – Live

Read more
CancerNet

Advances in the Treatment of Diffuse Large B Cell Lymphoma: ADCs, Bispecific Antibodies, CAR T Therapies and Combinations – Live

Read more
CancerNet

Myelofibrosis: Symptom Burden, Risk Stratification and Novel Treatments – Live

Read more
CancerNet

Ovarian Cancer: Optimizing the Management Based on Mutations and Biomarkers to Direct Treatment with PARP Inhibitors and Immunotherapy – Live

Read more
CancerNet

Changing Landscape of Diagnosis and Treatment of Multiple Myeloma – Live

Read more
CancerNet

Advances in Symptom Burden, Risk Stratification, and Treatment of Myelofibrosis – Live

Read more
CancerNet

Ovarian Cancer: Mutations, Biomarkers, and Treatment with PARP Inhibitors and Immunotherapy – Live

Read more
CancerNet

Immune Checkpoint and BRAF/MEK Inhibitor- directed Therapies for Advanced Melanoma – Live

Read more
CancerNet

Improving Renal Cell Carcinoma Patient Outcomes with Multi-targeted TKIs and Immune Checkpoint Inhibitors – Live

Read more
CancerNet

Current and Emerging Treatment Options for Multiple Myeloma – Live

Read more
CancerNet

Emerging Treatment Options for Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma – Live

Read more
CancerNet

Current and Emerging Treatment Options for Multiple Myeloma – Live

Read more
CancerNet

Novel Treatment Options for Multiple Myeloma – Live

Read more